Roger’s story: pancreatic cancer, caught in time
Roger felt healthy and low-risk. After reading about the test, he sought it out — and it caught a pancreatic cancer early, before symptoms.
Read moreRoger felt healthy and low-risk. After reading about the test, he sought it out — and it caught a pancreatic cancer early, before symptoms.
Read more
Executive health screening that looks beyond risk scores – with CT coronary angiography and the Galleri® cancer test, for leaders and the wider workforce.
Many conditions develop silently. See what a comprehensive annual blood test checks – from ApoB to HbA1c – and why tracking your results each year matters.
A firefighter of 30 years, Kevin felt healthy when his department offered the test. It flagged an early oesophageal cancer when Kevin had no symptoms
Heart disease often builds silently for decades. Learn what the REACT, SCOT-HEART and ORFAN studies reveal about plaque, inflammation and heart attack risk.
Robert joined the trial after losing both parents to cancer. Three rounds in, it flagged an early tongue-base cancer — before he had any symptoms.
Bowel cancer screening is changing. Learn how the NHS FIT test works, why its threshold matters and where blood tests like the Galleri® test could fit in.
In her seventies and feeling well, Ann joined the NHS-Galleri trial to help others — and it flagged a bowel cancer she never knew was there.
Consultant cardiologist Dr Michael Hickman explains why he founded Preologi – and why healthcare must stop waiting for people to become ill before it acts.
US coverage of early PATHFINDER 2 results: when the test flagged a signal, cancer was found most of the time, with very few false alarms.
University College London's announcement of the NHS-Galleri results — candid that the main goal wasn't met, alongside a fall in late-stage diagnoses.